ACR/ARHP 2016

EDITORIAL

EDITORIAL MANAGING EDITOR Anne Neilson anne.neilson@elsevier.com EDITOR Carolyn Ng carolyn.ng@elsevier.com DESIGNER Jana Sokolovskaja j.sokolovskaja@elsevier.com SALES COMMERCIAL MANAGER Fleur Gill fleur.gill@elsevier.com ACCOUNT MANAGER Linnea Mitchell-Taverner l.mitchell-taverner@elsevier.com

© ACR/ARHP 2016 Annual Meeting • acrannualmeeting.org

Changing paradigms in rheumatology

DISCLAIMER The Elsevier Conference Series provides highlights of key local and international conferences for specialist medical professionals. News stories are independently produced by the Elsevier Australia editorial team. The ideas and opinions expressed in this publication do not necessarily reflect those of the Publisher. Elsevier Australia will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Please consult the full current Product Information before prescribing any medication mentioned in this publication. Although all advertisingmaterial is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.

W elcome to our special coverage of the American College of Rheumatology and Association of Rheumatology Health Professionals Annual Meeting, part of the Elsevier Conference Series, that aims to bring you key clinical and scientific news from the world’s top medical congresses. This special ACR/ARHP 2016 Annual Meeting, kindly brought to you through advertising by Janssen Australia, brings together leading research from the top guns who are changing paradigms in rheumatology. Our Elsevier Australia news team has independently reported from the 4000 poster and oral presentations on show to bring you the best ACR/ARHP 2016 Annual Meeting, has to offer. Topics, we selected, that are creating this paradigm shift include: • New thinking on biologics in RA • Use of DMARDs through RA surgery • Intensive management regimes to reduce RA disease activity • Importance of early diagnosis and treatment for RA remission • Increased CV risk for RA patients • Emergence of gene expression signatures, and • Promise of Wnt inhibitors in OA We hope you enjoy this issue of the Elsevier Conference Series.

ELSEVIER AUSTRALIA ABN 70 001 002 357 475 Victoria Avenue Chatswood NSW 2067 Australia Locked Bag 7500 Chatswood DC NSW 2067 © 2016 Elsevier Inc. EMCS121601

Anne Neilson Managing Editor Elsevier Conference Series

3

ACR/ARHP 2016 Annual Meeting • Elsevier Conference Series

Made with